101 related articles for article (PubMed ID: 28950046)
1. Intravenous opioid drug abuse as an independent risk factor for supraglottic squamous cell carcinoma-A case-control study.
Shoffel-Havakuk H; Cohen O; Slavin M; Haimovich Y; Halperin D; Lahav Y
Clin Otolaryngol; 2018 Apr; 43(2):456-462. PubMed ID: 28950046
[TBL] [Abstract][Full Text] [Related]
2. Supraglottic Carcinoma in Intravenous Opioid Drug Abusers: A Distinct Disease with Improved Survival.
Yaniv D; Reuven Y; Lahav Y; Cohen O; Hamzany Y; Moore A; Rapana OG; Argaman N; Halperin D; Popovtzer A; Bachar G; Shoffel-Havakuk H
Laryngoscope; 2021 Apr; 131(4):E1190-E1197. PubMed ID: 32946621
[TBL] [Abstract][Full Text] [Related]
3. The rising rate of nonsmokers among laryngeal carcinoma patients: Are we facing a new disease?
Shoffel-Havakuk H; O'Dell K; Johns MM; Reder L; Popova M; Halperin D; Feldberg E; Lahav Y
Laryngoscope; 2020 Mar; 130(3):E108-E115. PubMed ID: 31090946
[TBL] [Abstract][Full Text] [Related]
4. Supraglottic and glottic carcinomas: epidemiologically distinct entities?
De Stefani E; Boffetta P; Deneo-Pellegrini H; Brennan P; Correa P; Oreggia F; Ronco AL; Mendilaharsu M
Int J Cancer; 2004 Dec; 112(6):1065-71. PubMed ID: 15386361
[TBL] [Abstract][Full Text] [Related]
5. Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe.
Hashibe M; Boffetta P; Zaridze D; Shangina O; Szeszenia-Dabrowska N; Mates D; Fabiánová E; Rudnai P; Brennan P
Am J Epidemiol; 2007 Apr; 165(7):814-20. PubMed ID: 17244634
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological Study of Laryngeal Carcinoma in Western Nepal.
Koirala K
Asian Pac J Cancer Prev; 2015; 16(15):6541-4. PubMed ID: 26434871
[TBL] [Abstract][Full Text] [Related]
7. Relationship between a family history of malignancy and the incidence of laryngeal carcinoma in the Liaoning province of China.
Li XY; Guo X; Feng S; Li XT; Wei HQ; Yang HA; Ren Z; Jiang XJ
Clin Otolaryngol; 2009 Apr; 34(2):127-31. PubMed ID: 19413610
[TBL] [Abstract][Full Text] [Related]
8. Laryngeal cancer: smoking is not the only risk factor.
Vassileiou A; Vlastarakos PV; Kandiloros D; Delicha E; Ferekidis E; Tzagaroulakis A; Nikolopoulos TP
B-ENT; 2012; 8(4):273-8. PubMed ID: 23409557
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of primary pyogenic spinal infections in intravenous recreational drug users.
Ziu M; Dengler B; Cordell D; Bartanusz V
Neurosurg Focus; 2014 Aug; 37(2):E3. PubMed ID: 25081963
[TBL] [Abstract][Full Text] [Related]
10. Intravenous drug abuse and Type 1 diabetes: financial and healthcare implications.
Saunders SA; Democratis J; Martin J; Macfarlane IA
Diabet Med; 2004 Dec; 21(12):1269-73. PubMed ID: 15569127
[TBL] [Abstract][Full Text] [Related]
11. Differences in the sex ratio of laryngeal cancer incidence rates by anatomic subsite.
Yang PC; Thomas DB; Daling JR; Davis S
J Clin Epidemiol; 1989; 42(8):755-8. PubMed ID: 2788212
[TBL] [Abstract][Full Text] [Related]
12. An epidemiological study of laryngeal cancer in Japan.
Iwamoto H
Laryngoscope; 1975 Jul; 85(7):1162-72. PubMed ID: 1152565
[TBL] [Abstract][Full Text] [Related]
13. Interaction effects and population-attributable risks for smoking and alcohol on laryngeal cancer and its subsites. A case-control study from Germany.
Ramroth H; Dietz A; Becher H
Methods Inf Med; 2004; 43(5):499-504. PubMed ID: 15702209
[TBL] [Abstract][Full Text] [Related]
14. Past sexual behaviors and risks of oropharyngeal squamous cell carcinoma: a case-case comparison.
Schnelle C; Whiteman DC; Porceddu SV; Panizza BJ; Antonsson A
Int J Cancer; 2017 Mar; 140(5):1027-1034. PubMed ID: 27859177
[TBL] [Abstract][Full Text] [Related]
15. Mu-Opioid Receptor Expression in Laryngeal Cancer.
Lahav Y; Cohen O; Huszar M; Levy I; Cata JP; Halperin D; Shoffel-Havakuk H
J Voice; 2023 May; 37(3):433-439. PubMed ID: 33750623
[TBL] [Abstract][Full Text] [Related]
16. [The clinical feature of laryngeal cancer in Yanbian area of China].
Cai Y; Jin L; Li R
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Aug; 12(8):356-7. PubMed ID: 11263157
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of cancer of the larynx: results of the Heidelberg case-control study.
Maier H; Gewelke U; Dietz A; Heller WD
Otolaryngol Head Neck Surg; 1992 Oct; 107(4):577-82. PubMed ID: 1437190
[TBL] [Abstract][Full Text] [Related]
18. Laryngeal dysplasia: Oncological outcomes in a large cohort of patients treated in a tertiary comprehensive cancer centre.
Chu F; De Santi S; Tagliabue M; De Benedetto L; Zorzi S; Pietrobon G; Herman I; Maffini F; Chiocca S; Corso F; Gandini S; Ansarin M
Am J Otolaryngol; 2021; 42(2):102861. PubMed ID: 33445041
[TBL] [Abstract][Full Text] [Related]
19. [Supraglottic and glottic carcinomas. Study of the incidence in the last 31 years].
Tamarit Conejeros JM; Carrasco Llatas M; Estellés Ferriol E; Fernández Martínez S; Baviera Granell N; Dalmau Galofre J
Acta Otorrinolaringol Esp; 2007 Dec; 58(10):449-53. PubMed ID: 18082073
[TBL] [Abstract][Full Text] [Related]
20. Influence of intravenous drug abuse on vascular access placement and survival in HIV-seropositive patients.
Eustace JA; Gregory PC; Krishnan M; Ni W; Kuhn DM; Astor BC; Scheel PJ
Nephron Clin Pract; 2005; 100(2):c38-45. PubMed ID: 15818057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
